Cargando…
ZEB1 transcription factor promotes immune escape in melanoma
BACKGROUND: The efficacy of immunotherapies in metastatic melanoma depends on a robust T cell infiltration. Oncogenic alterations of tumor cells have been associated to T cell exclusion. Identifying novel cancer cell-intrinsic non-genetic mechanisms of immune escape, the targeting of which would rei...
Autores principales: | Plaschka, Maud, Benboubker, Valentin, Grimont, Maxime, Berthet, Justine, Tonon, Laurie, Lopez, Jonathan, Le-Bouar, Myrtille, Balme, Brigitte, Tondeur, Garance, de la Fouchardière, Arnaud, Larue, Lionel, Puisieux, Alain, Grinberg-Bleyer, Yenkel, Bendriss-Vermare, Nathalie, Dubois, Bertrand, Caux, Christophe, Dalle, Stéphane, Caramel, Julie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921918/ https://www.ncbi.nlm.nih.gov/pubmed/35288462 http://dx.doi.org/10.1136/jitc-2021-003484 |
Ejemplares similares
-
An in vivo avian model of human melanoma to perform rapid and robust preclinical studies
por: Jarrosson, Loraine, et al.
Publicado: (2023) -
ZEB1‐mediated melanoma cell plasticity enhances resistance to MAPK inhibitors
por: Richard, Geoffrey, et al.
Publicado: (2016) -
NF-κB in Cancer Immunity: Friend or Foe?
por: Lalle, Guilhem, et al.
Publicado: (2021) -
Cancer Cell Phenotype Plasticity as a Driver of Immune Escape in Melanoma
por: Benboubker, Valentin, et al.
Publicado: (2022) -
Transcriptional Control of Regulatory T Cells in Cancer: Toward Therapeutic Targeting?
por: Stéphan, Pierre, et al.
Publicado: (2020)